Please interpret the ApneaLink Air sleep study results showing 6 apneas, 54 hypopneas, apnea‑hypopnea index (AHI) 7.4 events per hour, supine AHI 12.8, non‑supine AHI approximately 3–4, oxygen desaturation index (ODI) 6.3, baseline oxygen saturation (SpO₂) 98% and lowest SpO₂ 83%.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ApneaLink Air Sleep Study Interpretation

This study demonstrates mild obstructive sleep apnea (OSA) with an overall AHI of 7.4 events/hour, but reveals clinically significant positional OSA with supine AHI of 12.8 events/hour, indicating moderate OSA severity when supine. 1, 2

Severity Classification

Overall OSA Severity: Mild

  • The overall AHI of 7.4 events/hour falls into the mild OSA category (AHI 5-15 events/hour) according to American Academy of Sleep Medicine criteria 3, 1, 2
  • The study captured 6 apneas and 54 hypopneas over 8.07 hours of flow evaluation, yielding 60 total respiratory events 1
  • The apnea index (AI) of 0.7 is minimal, with hypopnea index (HI) of 6.6 accounting for the majority of respiratory events 1

Positional OSA: Clinically Significant

  • Supine AHI of 12.8 events/hour represents moderate OSA severity when supine (51.8% of recording time) 1, 2
  • Non-supine AHI of 3.3 events/hour is within normal range 1
  • The supine-to-non-supine ratio is approximately 3.9:1, far exceeding the 2.0 threshold for positional OSA 1, 4
  • This 2-3 fold increase in supine AHI compared to non-supine positions is characteristic of supine-predominant OSA 1

Oxygen Saturation Analysis

Oxygen Desaturation Pattern: Mild

  • ODI of 6.3 events/hour correlates well with the AHI of 7.4, confirming mild OSA severity 4, 5
  • The correlation between AHI and ODI is typically 0.97, and this patient's values show excellent concordance 4
  • Baseline SpO₂ of 98% and average SpO₂ of 97% indicate good overall oxygenation 6
  • Lowest SpO₂ of 83% represents moderate desaturation but occurred transiently with no time spent below 88% 6
  • Zero time with SpO₂ ≤90%, ≤88%, ≤85%, or ≤80% indicates absence of sustained hypoxemia 6, 5

Clinical Implications

Positional Therapy Candidacy

  • This patient is an excellent candidate for positional therapy given the marked difference between supine (AHI 12.8) and non-supine (AHI 3.3) positions 1
  • Devices or techniques that discourage supine sleep are specifically recommended when ≥70% of sleep time is supine and positional OSA is demonstrated 1
  • The patient spent 51.8% of time supine, and avoiding supine sleep could potentially reduce AHI to near-normal levels 1

Diagnostic Adequacy

  • This home sleep apnea test (HSAT) is technically adequate with 8+ hours of recording time and valid oximetry data throughout 3
  • The study was scored using AASM 2012 guidelines with manual scoring, meeting quality standards 3
  • No evidence of central sleep apnea (central AI 0.1) or Cheyne-Stokes respiration 3

Common Pitfalls and Caveats

Underestimation Risk

  • The overall AHI of 7.4 may underestimate true OSA severity because the patient spent only 51.8% of time supine 1
  • If this patient typically sleeps supine at home, the true nightly AHI may be closer to 12.8 events/hour (moderate OSA) 1
  • REM-predominant OSA often co-exists with positional dependence and can lead to further underestimation of disease severity 1

Night-to-Night Variability

  • Approximately 15% of patients show significant AHI variability between nights, and 6% with severe OSA may be missed on a single night study 7
  • If clinical suspicion remains high despite this mild result, consider repeat testing per American Academy of Sleep Medicine guidelines 3

Need for Confirmatory Testing

  • If this HSAT result is negative, inconclusive, or technically inadequate, polysomnography should be performed 3
  • Patients with significant cardiorespiratory disease, neuromuscular conditions, chronic opioid use, stroke history, or severe insomnia should undergo polysomnography rather than HSAT 3

Treatment Recommendations

Primary Approach: Positional Therapy

  • Given the 3.9-fold increase in AHI when supine, initial management should focus on supine avoidance strategies 1
  • If positional therapy fails to control symptoms or the patient cannot maintain non-supine sleep, consider CPAP therapy 3

Alternative Considerations

  • The moderate supine AHI of 12.8 may warrant CPAP therapy if symptoms are significant or cardiovascular risk factors are present 3
  • Clinical correlation with symptoms (daytime sleepiness, witnessed apneas, unrefreshing sleep) is essential for treatment decisions 3

References

Guideline

Obstructive Sleep Apnea: Severity Definitions, REM‑Predominant & Positional Features, and Sleep Architecture Indicators

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Thresholds for Sleep Apnea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

First-night-effect on polysomnographic respiratory sleep parameters in patients with sleep-disordered breathing and upper airway pathology.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2010

Related Questions

I have mild obstructive sleep apnea (apnea‑hypopnea index 5–15) and recent nasal surgery; based on my oxygen desaturation index and nadir SpO₂, are there any concerns about switching from continuous positive airway pressure (CPAP) to a mandibular advancement device, and should I obtain an off‑CPAP polysomnography to establish a current baseline?
With a mild obstructive sleep apnea (overall apnea‑hypopnea index 7.4 events per hour, supine apnea‑hypopnea index 12.8 events per hour, oxygen desaturation index 6.3 events per hour, baseline peripheral oxygen saturation 98% and nadir 83%), is there a risk of developing an atrioventricular nodal block?
Interpret this polysomnography: total sleep time 388 minutes, sleep efficiency 90 %, sleep latency 1 minute, REM latency 44 minutes, frequent awakenings up to 14 minutes, 15 respiratory events, overall apnea‑hypopnea index (AHI) 2.3 using 4 % desaturation (rising to 9 with 3 % desaturation), REM‑sleep AHI 7, non‑REM AHI <1, lowest oxygen saturation 84 %, snoring, and 71 % supine sleep.
What is the correlation between Oxygen Desaturation Index (ODI) and Apnea-Hypopnea Index (AHI)?
Given a polysomnography showing an overall apnea‑hypopnea index of 2.4 events per hour (normal), a REM‑specific apnea‑hypopnea index of 8.5 events per hour (mild) using a 3% desaturation criterion, a non‑REM apnea‑hypopnea index of 3.2 events per hour, an average awake oxygen saturation of 95% and a nadir saturation of 88% during sleep, what does this indicate and is any treatment required?
What are the contraindications to cyclosporine therapy?
What is the recommended taper schedule for an adult who has been taking 30 mg oral prednisone daily for several weeks?
What is the most likely diagnosis and recommended work‑up for a patient who presents with a rash confined to the bilateral cheeks, nasal folds, and chin?
In a patient taking Lexapro (escitalopram) 10 mg daily for 4 weeks who still has nausea, resting tachycardia, and jitteriness, what is the next management step?
What is the anxiety‑panic cycle and the recommended first‑line treatment?
In a 26-year-old Hispanic female with acute right-sided facial droop and inability to fully close the right eye, what history questions should be asked, what pertinent physical exam findings are needed, what are the differential diagnoses, and what is the appropriate treatment plan?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.